M. Hale, A. Nicholls, R. Bullingham
Dec 1, 1998
Citations
20
Influential Citations
407
Citations
Quality indicators
Journal
Clinical Pharmacology & Therapeutics
Abstract
Mycophenolate mofetil, a pro‐drug for mycophenolic acid, reduces the likelihood of allograft rejection after renal transplantation. We studied the relationship between mycophenolic acid pharmacokinetics and the likelihood of rejection in a randomized concentration‐controlled trial.